Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems

J Autism Dev Disord. 2012 Jun;42(6):1037-44. doi: 10.1007/s10803-011-1338-2.

Abstract

The Research Units on Pediatric Psychopharmacology--Autism Network reported additional benefit when adding parent training (PT) to antipsychotic medication in children with autism spectrum disorders and serious behavior problems. The intent-to-treat analyses were rerun with putative predictors and moderators. The Home Situations Questionnaire (HSQ) and the Hyperactivity/Noncompliance subscale of the Aberrant Behavior Checklist were used as outcome measures. Candidate predictors and moderators included 21 demographics and baseline measures of behavior. Higher baseline HSQ scores predicted greater improvement on the HSQ regardless of treatment assignment, but no other predictors of outcome were observed. None of the variables measured in this study moderated response to PT. Antipsychotic medication plus PT appears to be equally effective for children with a wide range of demographic and behavioral characteristics.

Trial registration: ClinicalTrials.gov NCT00080145.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antipsychotic Agents / therapeutic use
  • Child
  • Child Behavior Disorders / drug therapy
  • Child Behavior Disorders / psychology*
  • Child Development Disorders, Pervasive / drug therapy
  • Child Development Disorders, Pervasive / psychology*
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Parent-Child Relations*
  • Parents / education*
  • Parents / psychology
  • Predictive Value of Tests
  • Risperidone / therapeutic use
  • Surveys and Questionnaires
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Risperidone

Associated data

  • ClinicalTrials.gov/NCT00080145